Th2-dependent B cell responses in the absence of CD40-CD40 ligand interactions

Journal of Immunology

Volumn 164, Issue 1, 2000, Pages 248-255

  Chirmule, Narendra ^a   Tazelaar, John ^a   Wilson, James M ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN;

ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; HAMSTER; HUMORAL IMMUNITY; IMMUNOSTIMULATION; LIGAND BINDING; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033981523     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.1.248     Document Type: Article

References (52)

1. Szomolanyi-Tsuda, E., and R. Welsh. 1998. T-cell-independent antiviral antibody responses. Immunology 10:431.
2. Yu, M., M. Leavitt, M. Maruyama, O. Yamada, D. Young, A. Ho, and F. Wong-Staal. 1995. Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type I. Proc. Natl. Acad. Sci. USA 92:699.
3. Lane, P., C. Burdet, F. McConnell, A. Lanzavecchia, and E. Padovan. 1995. CD40 ligand-independent B cell activation revealed by CD40 ligand-deficient T cell clones: evidence for distinct activation requirements for antibody formation and B cell proliferation. Eur. J. Immunol. 25:1788.
4. + T lymphocytes generates a signal that up-regulates IL-4 synthesis. J. Immunol. 156:3133.
5. Poudrier, J., D. van Essen, S. Morales-Alcelay, T. Leanderson, S. Bergthorsdottir, and D. Gray. 1998. CD40 ligand signals optimize T helper cell cytokine production: role in Th2 development and induction of germinal centers. Eur. J. Immunol. 28:3371.
6. Foy, T. M., J. D. Laman, J. A. Ledbetter, A. Aruffo, E. Claassen, and R. J. Noelle. 1994. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180:157.
7. Xu, J., T. Foy, J. Laman, E. Elliott, J. Dunn, T. Waldschmidt, J. Elsemore, R. Noelle, and R. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity 1:423.
8. Renshaw, B., W. Fanslow, R. Armitage, K. Campbell, D. Liggitt, B. Wright, B. Davison, and C. Maliszewski. 1994. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180:1889.
9. Grewal, I. S., and R. A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:111.
10. van Kooten, C., and J. Banchereau. 1997. Functions of CD40 on B cells, dendritic cells and other cells. Curr. Opin. Immunol. 9:330.
11. Kehry, M. R. 1996. CD40-mediated signaling in B cells: balancing cell survival, growth, and death. J. Immunol. 156:2345.
12. Kindler, V., and R. H. Zubler. 1997. Memory, but not naive, peripheral blood B lymphocytes differentiate into Ig-secreting cells after CD40 ligation and costimulation with IL-4 and the differentiation factors IL-2, IL-10, and IL-3. J. Immunol. 159:2085.
13. Randall, T., A. Heath, L. Santos-Argumedo, M. Howard, I. Weissman, and F. Lund. 1998. Arrest of B lymphocyte terminal differentiation by CD40 signaling: mechanism for lack of antibody-secreting cells in germinal centers. Immunity 8:733.
14. Gray, D., K. Siepmann, D. van Essen, J. Poudrier, M. Wykes, S. Jainandunsing, S. Bergthorsdottir, and P. Dullforce. 1996. B-T lymphocyte interactions in the generation and survival of memory cells, Immunol. Rev. 150:45.
15. Fujieda, S., K. Zhang, and A. Saxon. 1995. IL-4 plus CD40 monoclonal antibody induces human B cells γ subclass-specific isotype switch: switching to γ1, γ3, and γ4, but not γ2. J. Immunol. 155:2318.
16. Rathmell, J. C., S. E. Townsend, J. C. Xu, R. A. Flavell, and C. C. Goodnow. 1996. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 87:319.
17. Han, S., K. Hathcock, B. Zheng, T. B. Kepler, R. Hodes, and G. Kelsoe. 1995. Cellular interaction in germinal centers: roles of CD40 ligand and B7-2 in established germinal centers. J. Immunol. 155:556.
18. Grewal, I. S., J. Xu, and R. A. Flavell. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378:617.
19. van Essen, D., H. Kikutani, and D. Gray. 1995. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378:620.
20. Yang, Y., G. Trinchieri, and J. M. Wilson. 1995. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat. Med. 1:890.
21. Yang, Y., Q. Su, I. S. Grewal, R. Schilz, R. A. Flavell, and J. M. Wilson. 1996. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues. J. Virol. 70:6370.
22. Yang, Y., and J. M. Wilson. 1996. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science 273:1862.
23. + T-helper and a T-killer cell. Nature 393: 474.
24. Bennett, S. R., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. Miller, and W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signaling. Nature 393:478.
25. Schoenberger, S. P., R. E. Toes, E. I. van der Voort, R. Offringa, and C. J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480.
26. Yang, Y., Q. Li, H. C. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004.
27. Engelhardt, J. F., X. Ye, B. Doranz, and J. M. Wilson. 1994. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91:6196.
28. Chirmule, N., J. V. Hughes, G.-P. Gao, S. E. Raper, and J. M. Wilson. 1998. Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs. J. Virol. 72:6138.
29. Chirmule, N., A. Truneh, S. A. Haecker, J. T. Tazelaar, G.-P. Gao, S. E. Raper, J. V. Hughes, and J. M. Wilson. 1999. Repeated administration of adenoviral vectors in lungs of human CD4 transgenic mice treated with a non-depleting CD4 antibody. J. Immunol. 163:448.
30. Borriello, F., M. P. Sethna, S. D. Boyd, A. N. Schweitzer, E. A. Tivol, D. Jacoby, T. B. Strom, E. M. Simpson, G. J. Freeman, and A. H. Sharpe. 1997. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6:303.
31. Lenschow, D. J., K. C. Herold, L. Rhee, B. Patel, A. Koons, H. Y. Qin, E. Fuchs, B. Singh, C. B. Thompson, and J. A. Bluestone. 1996. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. [Published erratum appears in 1997, Immunity 6:215.] Immunity 5:285.
32. Rulifson, I. C., A. I. Sperling, P. E. Fields, F. W. Fitch, and J. A. Bluestone. 1997. CD28 costimulation promotes the production of Th2 cytokines. J. Immunol. 158: 658.
33. Kozbor, D., A. Moretta, H. A. Messner, L. Moretta, and C. M. Croce. 1987. TP44 molecules involved in antigen independent T cell activation are expressed on human plasma cells. J. Immunol. 138:4128.
34. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233.
35. Allen, R., R. Armitage, M. Conley, H. Rosenblatt, N. Jenkins, N. Copeland, M. Bedell, S. Edelhoff, C. Disteche, D. K. Simoneaux, et al. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259:990.
36. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L. Grosmaire, R. Stenkamp, M. Neubauer, et al. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72:291.
37. Klaus, S. J., I. Berberich, G. Shu, and E. A. Clark. 1994. CD40 and its ligand in the regulation of humoral immunity. Semin. Immunol. 6:279.
38. Gray, D., S. Bergthorsdottir, D. van Essen, M. Wykes, J. Poudrier, and K. Siepmann. 1997. Observations on memory B-cell development. Semin. Immunol. 9:249.
39. + T cells that induces contact-dependent B cell differentiation (help). J. Exp. Med. 175:1091.
40. Noelle, R. J. 1998. CD40 and its ligand in cell-mediated immunity. Agents Actions Suppl. 49:17.
41. Brenner, B., U. Koppenhoeffer, H. Grassme, J. Kun, F. Lang, and E. Gulbins. 1997. Evidence for a novel function of the CD40 ligand as a signalling molecule in T-lymphocytes. FEBS Lett. 17:301.
42. Worm, M., A. Tsytsykova, and R. Geha. 1998. CD40 ligation and IL-4 use different mechanisms of transcriptional activation of the human lymphotoxin α promoter in B cells. Eur. J. Immunol. 28:901.
43. Marshall, L. S., D. M. Shepard, J. A. Ledbetter, A. Arruffo, and R. J. Noelle. 1994. Signaling events during helper T cell-dependent B cell activation. I. Analysis of the signal transduction pathways triggered by activated helper T cell in resting B cells. J. Immunol. 152:4816.
44. Knox, K., and J. Gordon. 1993. Protein tyrosine phosphorylation is mandatory for CD40-mediated rescue of germinal center B cells from apoptosis. Eur. J. Immunol. 23:2578.
45. Ren, C. L., T. Morio, S. M. Fu, and R. S. Geha. 1994. Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase Cγ2. J. Exp. Med. 179:673.
46. Faris, M., F. Gaskin, J. T. Parsons, and S. M. Fu. 1994. CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of 28-kD tyrosine phosphorylated protein. J. Exp. Med. 179:1923.
47. L, Cdk4, and Cdk6: implication of their cooperation in selective B cell growth. J. Immunol. 155:5527.
48. Rothe, M., V. Sarma, V. M. Dixit, and D. V. Goeddel. 1995. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269:1424.
49. Cheng, G., A. M. Cleary, Z. S. Ye, D. I. Hong, S. Lederman, and D. Baltimore. 1995. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267:1494.
50. Moore, P. A., O. Belvedere, A. Orr, K. Pieri, D. W. LaFleur, P. Feng, D. Soppet, M. Charters, R. Gentz, D. Parmelee, et al. 1999. BLyS: member of the tumor necrosis family and B lymphocyte stimulator. Science 285:160.
51. Akiba, H., H. Oshima, K. Takeda, M. Atsuta, H. Nakano, A. Nakajima, C. Nohara, H. Yagita, and K. Okumura. 1999. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells. J. Immunol. 162:7058.
52. Flynn, S., K. M. Toellner, C. Raykundalia, M. Goodall, and P. Lane. 1998. CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. J. Exp. Med 188:297.